Biotech Values

[mskatiescarletohara]

Recently, OXGN’s CEO and CSO bought $14-15K each of shares on the open market, which I criticized as token, cosmetic purchases

A very feeble attempt to appease shareholder concerns, I think matters are that bad regarding the world leader's VTA...CA4P. There was a reason why BMY pulled out, and the original members of management left when OXGN revealed the Phase I data. Yah, it's the cardiotoxicstuff.

katie....